FEMTOPRINT: Glass Microfabrication for Lab-on-a-Chip Innovation

In the race to deliver next-generation Lab-on-a-Chip (LoC) platforms

In the race to deliver next-generation Lab-on-a-Chip (LoC) platforms, CTOs and R&D leaders in Life Sciences and MedTech face a dual challenge: compressing development timelines while ensuring uncompromising reliability and compliance. Traditional approaches, fragmented, polymer-based, or multi-material assemblies and introduce failure points, integration hurdles, and scale-up risks.

FEMTOPRINT is redefining this paradigm. By harnessing proprietary 3D laser microfabrication in glass, FEMTOPRINT provides a direct path from concept to industrially scalable, regulatory-ready LoC platforms without compromise.

The Power of Monolithic Glass Integration

At the core of FEMTOPRINT’s platform lies true monolithic integration. Microchannels, reservoirs, nozzles, optical windows, and functional interfaces are embedded into a single hermetically sealed glass substrate. For scientific executives, this translates into a decisive technical edge:

Eliminated failure points – no bonding, gluing, or hybrid materials.
Biocompatibility & inertness – glass is the gold standard for biological assays, long-term stability, and chemical resistance.
Superior analytics – unmatched optical clarity for high-resolution, real-time sensing.
Rapid prototyping → wafer-level manufacturing – compressing design-to-validation cycles, critical for competitive advantage.
Submicron precision – enabling design freedom for sophisticated biomedical architectures.

This is not an incremental improvement, it is a new design paradigm for Lab-on-a-Chip innovation.

Strategic Applications with Direct Market Impact

For leaders driving innovation pipelines in diagnostics, drug discovery, and organ-on-chip R&D, FEMTOPRINT’s glass microfabrication is not just a technical enabler, it is a competitive weapon.

Point-of-care diagnostic chips – delivering process integrity and reliable clinical data.
Implantable microdevices – exploiting glass’s superior mechanical and chemical properties for safe, long-term performance.
Custom optofluidic and biophotonic integrations – powering AI-driven analytics and personalized medicine platforms.

By eliminating scale-up risks and reducing regulatory friction, FEMTOPRINT enables CTOs to shorten time-to-market while strengthening IP defensibility.

Regulatory Confidence, Engineering Precision

Innovation without compliance is a liability. FEMTOPRINT operates under ISO 13485:2016 and ISO 9001:2015, ensuring consistency, quality, and regulatory readiness from prototype to production. Our team partners directly with R&D executives to:

Accelerate design iteration and functional testing aligned with international standards.
Co-develop advanced devices through strategic partnerships, reducing development risk.
Scale seamlessly from pilot studies to industrial manufacturing with proprietary, wafer-level processes .

As the competitive landscape intensifies, differentiation lies not in incremental gains but in architectural leaps. FEMTOPRINT delivers exactly that: a proven microfabrication platform that

Schedule a free consultation – Call us now.